The Immunology & Preclinical Research Team at EpiVax, Inc. focuses on advancing the understanding and application of immunological principles through computational analysis and experimental research. They are responsible for designing and conducting preclinical studies, developing novel immunotherapies, and validating computational predictions in the lab to drive innovative solutions in immunotherapy and vaccine development.
View all